Lubecka, K.; Kaufman-Szymczyk, A.; Cebula-Obrzut, B.; Smolewski, P.; Szemraj, J.; Fabianowska-Majewska, K.
Novel Clofarabine-Based Combinations with Polyphenols Epigenetically Reactivate Retinoic Acid Receptor Beta, Inhibit Cell Growth, and Induce Apoptosis of Breast Cancer Cells. Int. J. Mol. Sci. 2018, 19, 3970.
https://doi.org/10.3390/ijms19123970
AMA Style
Lubecka K, Kaufman-Szymczyk A, Cebula-Obrzut B, Smolewski P, Szemraj J, Fabianowska-Majewska K.
Novel Clofarabine-Based Combinations with Polyphenols Epigenetically Reactivate Retinoic Acid Receptor Beta, Inhibit Cell Growth, and Induce Apoptosis of Breast Cancer Cells. International Journal of Molecular Sciences. 2018; 19(12):3970.
https://doi.org/10.3390/ijms19123970
Chicago/Turabian Style
Lubecka, Katarzyna, Agnieszka Kaufman-Szymczyk, Barbara Cebula-Obrzut, Piotr Smolewski, Janusz Szemraj, and Krystyna Fabianowska-Majewska.
2018. "Novel Clofarabine-Based Combinations with Polyphenols Epigenetically Reactivate Retinoic Acid Receptor Beta, Inhibit Cell Growth, and Induce Apoptosis of Breast Cancer Cells" International Journal of Molecular Sciences 19, no. 12: 3970.
https://doi.org/10.3390/ijms19123970
APA Style
Lubecka, K., Kaufman-Szymczyk, A., Cebula-Obrzut, B., Smolewski, P., Szemraj, J., & Fabianowska-Majewska, K.
(2018). Novel Clofarabine-Based Combinations with Polyphenols Epigenetically Reactivate Retinoic Acid Receptor Beta, Inhibit Cell Growth, and Induce Apoptosis of Breast Cancer Cells. International Journal of Molecular Sciences, 19(12), 3970.
https://doi.org/10.3390/ijms19123970